Table 3.
Study | Year | Participant selection | Confounding | Measurement of exposure | Blinding | Incomplete outcome data | Total |
---|---|---|---|---|---|---|---|
Abdolreza et al27 | 2011 | 1 | 1 | 1 | 1 | 1 | 5 |
Al Assaad et al28 | 2018 | 2 | 1 | 2 | 1 | 1 | 7 |
Al-Hadramy et al22 | 1997 | 1 | 1 | 2 | 1 | 1 | 6 |
Al Mahayni et al20 | 2018 | 1 | 1 | 2 | 1 | 1 | 6 |
Basiri et al23 | 2004 | 1 | 1 | 2 | 1 | 1 | 6 |
Cevik et al24 | 2016 | 2 | 2 | 2 | 1 | 1 | 8 |
Habib et al25 | 2014 | 1 | 1 | 1 | 1 | 1 | 5 |
Hodgkinson et al26 | 1976 | 1 | 1 | 1 | 1 | 1 | 5 |
Miladipour et al19 | 2012 | 1 | 1 | 1 | 1 | 1 | 5 |
Sagy et al21 | 2017 | 2 | 2 | 2 | 1 | 1 | 8 |
Adapted from the RoBANS tool.39 A score of “1” indicates low-risk, “2” indicates high-risk, and “0’ is unclear.